Sun Pharmaceutical Industries Share Price Today - Live Blog for November 25, 2025

Sun Pharmaceutical Industries Ltd's stock price surged by 0.04%, reaching the current market value of ₹1,771.75 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.38%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,771.20, and market participants are assessing the implications. The stock has a PE ratio of 40.7600, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd observed a -0.14% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,778.25. The stock has a PE ratio of 40.7600, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.11%, signalling a challenging period. Currently trading at ₹1,781.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.06% drop, and it's now trading at ₹1,782.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.11%, reaching a current market price of ₹1,783.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd experienced a -0.03% downturn in its share price, and it's currently trading at ₹1,785.40. This situation is generating interest among value investors who are evaluating the stock's potential.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.03% in its share price, and it currently trades at ₹1,785.40 per share. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

Following a noteworthy 0.05% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,785.90. When it comes to valuation, this stock has a PE ratio of 40.7600, with the industry PE ratio at 33.0081.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.13%, a development that warrants careful analysis. Presently trading at ₹1,787.10, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.03% uptick in its share price. As a result, it's now actively trading at ₹1,787.70 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd experienced a -0.01% downturn in its share price, and it's currently trading at ₹1,787.50. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd shares saw a -0.22% decrease, reaching a current market price of ₹1,787.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 40.7600, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.21%. At this moment, it's actively trading at ₹1,791.15, presenting an enticing opportunity for those in the market.

Sun Pharmaceutical Industries Ltd witnessed a -0.05% drop in its share price and is currently trading at ₹1,788.25. With the stock's PE at 40.7600 and the industry PE at 33.0081, investors are weighing their options.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.27% uptick in its share price. As a result, it's now actively trading at ₹1,789.00 per share, making it an attractive option for investors.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.06%. At this moment, it's actively trading at ₹1,784.25, presenting an enticing opportunity for those in the market.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.11%. At this moment, it's actively trading at ₹1,783.20, presenting an enticing opportunity for those in the market.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.20%, reaching the current market price of ₹1,781.50. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.16%, reaching a current market price of ₹1,777.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.16% drop, and it's now trading at ₹1,780.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

With a -0.16% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,780.60. The stock is currently trading at a PE of 40.7600, while the industry PE is 33.0081, prompting investors to assess its value proposition.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.16% decline, and it currently trades at ₹1,780.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.06%, a development that warrants careful analysis. Presently trading at ₹1,784.35, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.24% uptick in its share price. As a result, it's now actively trading at ₹1,783.45 per share, making it an attractive option for investors.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.18% recently. As of now, this stock is actively trading at a current market price of ₹1,779.25 per share, attracting attention from investors.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.17% increase and currently trading at ₹1,775.95 per share. This upward trajectory is turning heads in the market.